01
Content
Liverpool, New York (April 26, 2021) Supurva Healthcare Group, Inc. (the
“Company”) (OTC: SPRV) announces that immediately following the effectiveness of the
recently filed confidential Registration Statement, management will announce a Shareholder
Meeting to discuss their growth plans over the next 12 months.
John Murphy, the Company’s CEO, summarized as follows, “We have already filed a confidential
Registration Statement with the SEC, and once our Registration Statement is deemed
effective, management will immediately schedule a Shareholder Meeting to discuss Supurva’s
business plans and strategy over the next 12 months. This will include an eventual
authorized capital share reduction in line with ongoing restructuring goals. I would also
like to inform our current shareholders and the investment community that our tradable float
is 116,561,268 shares, and we will be updating that number with OTC Markets.
“The Company remains poised to expand its portfolio of medical office buildings (“MOBs”) as
recently outlined in our Press Release, dated March 21, 2021, while simultaneously building
measurable intrinsic shareholder value in the MOB sector.”
“We anticipate providing even more details of our progress over the near-term in as full and
transparent of a manner as possible while adhering to good corporate governance guidelines.
I am personally thrilled to finally have Supurva positioned for meaningful growth over the
next 12 months and am looking forward to keeping our shareholders and the investment
community at large aware of our material progress at every juncture.” CEO Murphy concluded